Trial reportDrug design, development and therapy2026
The Median Effective Dose of Phenylephrine Infusion for Prevention of Spinal-Induced Hypotension During Cesarean Delivery in the 15° Left-Tilt vs. Supine Positions: A Randomised Control Study.
Trial report in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- No Significant Difference Is Not Equivalence: Statistical Considerations on Phenylephrine Requirement in Left-Tilt versus Supine Cesarean Delivery [Response to Letter].Drug design, development and therapy · 2026Article
- No Significant Difference is not Equivalence: Statistical Considerations on Phenylephrine Requirement in Left-Tilt versus Supine Cesarean Delivery [Letter].Drug design, development and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Left uterine displacement is presumed to decrease vasopressor requirements during cesarean delivery due to decreased aortocaval compression, but studies have been equivocal. Our primary aim was to determine the median effective dose (ED Methods: Eighty pregnant women were randomly allocated to be positioned either at a 15° left tilt (group L) or supine (group S) during elective cesarean delivery. A Prophylactic phenylephrine was started immediately after intrathecal injection. In each group, the first patient received phenylephrine infusion at 0.5 µg/kg/min. Each subsequent patient received an infusion with an incremental dose of 0.05 μg/kg/min above or below the initial dose, depending on the response of the preceding patient. ED50 values for phenylephrine were calculated using the up-down sequential methodology and compared using relative median potency ratios. Results: The ED50 of a phenylephrine infusion was 0.33 µg/kg/min (95% confidence interval (CI), 0.23 to 0.39 µg/kg/min) in group L and 0.30 µg/kg/min (95% CI, 0.22 to 0.37 µg/kg/min) in group S. The relative median potency for phenylephrine in group L vs. group S was 1.06 (95% CI, 0.86 to 1.45). Conclusion: A 15 left tilt did not significantly alter phenylephrine requirements; therefore, routine use of tilt solely to reduce vasopressor need may not be necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.